San Diego, CA
Ryne Biotechnology focuses on developing therapies for neurodegenerative movement disorders. The company was founded in 2022 and is headquartered in Cambridge, Massachusetts, United States.
ryne-bio.comThese are collections Ryne Biotechnology is a part of. Click on the collection name to view similar companies.
Series A
$82,000,000
Grant
$4,000,000
Seed
$3,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Ryne Biotechnology.